Asia Pacific Surgical Stapling Devices Market Forecast to 2028 -Regional Analysis

The Asia Pacific surgical stapling devices market was valued at US$ 985.06 million in 2022 and is projected to reach US$ 1,657.88 million by 2028. It is estimated to grow at a CAGR of 9.1% from 2022 to 2028.

Technological Advancement to Drive Asia Pacific Surgical Stapling Devices Market Growth

The tremendous growth in the patient population worldwide has created a demand for advanced and effective medical devices for better treatments and outcomes, which forces medical device manufacturers to innovate and develop new technologies for the upgrading of existing devices. These innovative and technologically advanced products are also meant to simplify the work of healthcare professionals. The companies are using robotics and automated technologies that accelerate operational efficiency and reduce surgery time. Moreover, a decrease in the need for manual interference reduces complications and chances of tissue damage. For instance, in 2021, Intuitive launched the first surgical stapler with robotic-assisted technology, which helps in automatic adjustments while firing staples. It also provides 120° articulation in all directions. This has also increased the application areas of these surgical stapling devices in various procedures, especially in minimally invasive procedures such as laparoscopy and arthroscopy. Additionally, in 2017, Medtronic launched a smart surgical stapler named Signia stapling system, which detects the tissue thickness and automatically adjusts the stapler’s speed. This will help healthcare professionals to maintain consistency and uniformity in stapling after surgery or during wound closure. Such technological advancement in surgical stapling devices is further expected to reduce manual errors and leakage with improved healing. They would also make it easy to reach complicated sites of a human body.

Asia Pacific Surgical Stapling Devices Market Overview

The Asia Pacific surgical stapling devices market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to register the highest CAGR during the forecast period. The market growth in this region is attributed to the rising number of plastic surgeries, and the flourishment of medical tourism in emerging economies such as South Korea and India. Moreover, an increase in the number of product launches and a surge in healthcare expenditure are expected to fuel the market growth during the forecast period. The increasing incidence of cardiovascular disease (CVD) leads to a burden on the healthcare sector in China. The country recorded ~106 million CVD patients in 2019, including 33 million stroke cases. According to the 2022 report by Cardiovascular Diabetology, in China, CVDs contribute to more than 40% of total deaths. Furthermore, ischemic heart disease was the second major cause of death, and the age-standardized mortality rate (ASMR) was 103.16 per 100,000 in 2020. The elevated number of cases of high blood pressure is the leading cause of vast CVD prevalence in the country. Thus, the increasing need for surgeries for treating CVDs, in turn, creates a high demand for surgical stapling devices in China.

Asia Pacific Surgical Stapling Devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Surgical Stapling Devices Market Segmentation

The Asia Pacific surgical stapling devices market is segmented on the basis of product, type, application, end user, and country.

Based on product, the market is segmented into powered surgical staplers and manual surgical staplers. The powered surgical staplers segment accounted for a larger market share in 2022.

Based on type, the Asia Pacific surgical stapling devices market is segmented into disposable surgical staplers and reusable surgical staplers. The disposable surgical staple segment held a larger market share in 2022.

Based on application, the Asia Pacific surgical stapling devices market is segmented into orthopedic surgery, endoscopic surgery, cardiac and thoracic surgery, abdominal and pelvic surgery, and others. The orthopedic surgery segment registered the largest market share in 2022.

Based on end user, the Asia Pacific surgical stapling devices market is segmented into hospitals and ambulatory surgical centers. The hospitals segment accounted for a larger market share in 2022.

Based on country, the Asia Pacific surgical stapling devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in this region in 2022.

3M Co, B. Braun SE, Conmed Corp, Ethicon USA LLC, Frankenman International Ltd, Intutive Surgical Inc, Medtronic Plc, and Panther Healthcare Medical Equipment Co Ltd are the leading companies operating in the Asia Pacific surgical stapling devices market.